These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 1991970)
21. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells. Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249 [TBL] [Abstract][Full Text] [Related]
22. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic. Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516 [TBL] [Abstract][Full Text] [Related]
23. Relative inefficiency of soluble recombinant CD4 for inhibition of infection by monocyte-tropic HIV in monocytes and T cells. Gomatos PJ; Stamatos NM; Gendelman HE; Fowler A; Hoover DL; Kalter DC; Burke DS; Tramont EC; Meltzer MS J Immunol; 1990 Jun; 144(11):4183-8. PubMed ID: 2341717 [TBL] [Abstract][Full Text] [Related]
24. Synthetic peptides of human CD4 enhance binding of Ig to monocyte/macrophage cells. I. Characterization and mapping studies. Lenert P; Mehta RL; Zanetti M J Immunol; 1992 Mar; 148(6):1759-63. PubMed ID: 1541816 [TBL] [Abstract][Full Text] [Related]
25. Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV. Lederman S; Gulick R; Chess L J Immunol; 1989 Aug; 143(4):1149-54. PubMed ID: 2545782 [TBL] [Abstract][Full Text] [Related]
26. Sulfated polyanions prevent HIV infection of lymphocytes by disruption of the CD4-gp120 interaction, but do not inhibit monocyte infection. Lynch G; Low L; Li S; Sloane A; Adams S; Parish C; Kemp B; Cunningham AL J Leukoc Biol; 1994 Sep; 56(3):266-72. PubMed ID: 7521897 [TBL] [Abstract][Full Text] [Related]
27. Ability of anti-HIV agents to inhibit HIV replication in monocyte/macrophages or U937 monocytoid cells under conditions of enhancement by GM-CSF or anti-HIV antibody. Perno CF; Cooney DA; Currens MJ; Rocchi G; Johns DG; Broder S; Yarchoan R AIDS Res Hum Retroviruses; 1990 Aug; 6(8):1051-5. PubMed ID: 2223241 [TBL] [Abstract][Full Text] [Related]
28. Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Dis Markers; 1990; 8(1):36-7. PubMed ID: 1968801 [No Abstract] [Full Text] [Related]
29. Polyionic compounds selectively alter availability of CD4 receptors for HIV coat protein rgp120. Weaver JL; Gergely P; Pine PS; Patzer E; Aszalos A AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1125-30. PubMed ID: 1979910 [TBL] [Abstract][Full Text] [Related]
30. Development and characterization of a whole-cell radioligand binding assay for [125I]gp120 of HIV-1. To LP; Balasubramanian V; Charlton ME; Francis TA; Doyle C; Sweetnam PM J Immunoassay; 1992; 13(1):61-83. PubMed ID: 1569213 [TBL] [Abstract][Full Text] [Related]
31. Red blood cells bearing CD4 bind to gp120 covered plates and aggregate with cells expressing gp120. Arvinte T; Schulz B; Madoulet C; Nicolau C J Acquir Immune Defic Syndr (1988); 1990; 3(11):1041-5. PubMed ID: 1698964 [TBL] [Abstract][Full Text] [Related]
33. Quantitative measurements of recombinant HIV surface glycoprotein 120 binding to several glycosphingolipids expressed in planar supported lipid bilayers. Conboy JC; McReynolds KD; Gervay-Hague J; Saavedra SS J Am Chem Soc; 2002 Feb; 124(6):968-77. PubMed ID: 11829604 [TBL] [Abstract][Full Text] [Related]
34. Construction and characterization of a radio-iodinatable mutant of recombinant human CD4. Ferrer M; Godbout KL; Sullivan BJ; Austen DA; Sanderson CT; Kelley KC; Osburne MS; Harrison SC; van Schravendijk MR J Immunol Methods; 1997 Dec; 210(2):215-25. PubMed ID: 9520304 [TBL] [Abstract][Full Text] [Related]
35. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. Sonza S; Maerz A; Deacon N; Meanger J; Mills J; Crowe S J Virol; 1996 Jun; 70(6):3863-9. PubMed ID: 8648722 [TBL] [Abstract][Full Text] [Related]
36. Interferon-gamma-activated monocytes impair infectivity of HIV particles by an oxygen metabolite-dependent reaction. Ennen J; Kurth R Immunology; 1993 Feb; 78(2):171-6. PubMed ID: 8473009 [TBL] [Abstract][Full Text] [Related]
37. Separation and partial characterization of proteinases with substrate specificity for basic amino acids from human MOLT-4 T lymphocytes: identification of those inhibited by variable-loop-V3 peptides of HIV-1 (human immunodeficiency virus-1) envelope glycoprotein. Harvima IT; Harvima RJ; Nilsson G; Ivanoff L; Schwartz LB Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):711-8. PubMed ID: 8318003 [TBL] [Abstract][Full Text] [Related]
38. Modulation of the effector function of human monocytes for Mycobacterium avium by human immunodeficiency virus-1 envelope glycoprotein gp120. Shiratsuchi H; Johnson JL; Toossi Z; Ellner JJ J Clin Invest; 1994 Feb; 93(2):885-91. PubMed ID: 8113420 [TBL] [Abstract][Full Text] [Related]
39. Association of T cell and macrophage dysfunction with surface gp 120-immunoglobulin-complement complexes in HIV-infected patients. Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G Clin Exp Immunol; 1993 Aug; 93(2):152-6. PubMed ID: 8102328 [TBL] [Abstract][Full Text] [Related]
40. Characterization of a novel binding site for the human immunodeficiency virus type 1 envelope protein gp120 on human fetal astrocytes. Ma M; Geiger JD; Nath A J Virol; 1994 Oct; 68(10):6824-8. PubMed ID: 8084022 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]